PTMS and rheumatoid arthritis: In the present study, we identified five novel autoantibodies with possible diagnostic value in ACPA‐negative RA (anti‐ANAPC15, anti‐LSP1, anti‐APBB1, anti‐PTMS, and anti‐UBL7), especially in the early stage.